{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-035160","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.829492+00:00","generated_at":"2026-05-31T12:03:41.075752+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sangamo posts Q2 net loss $0.18/sh, cash $27.8M; signs Genentech deal for up to $1.9B","bullets":["Signed global license with Genentech for zinc finger repressors targeting tau and STAC-BBB capsid; $50M near-term, up to $1.9B milestones plus royalties.","Q2 net loss $36.1M ($0.18/sh) vs $114.5M ($0.66); revenue $0.3M down from $6.8M.","Cash $27.8M at June 30; with Genentech $50M, runway into Q1 2025.","Pfizer's Phase 3 hemophilia A gene therapy met primary endpoint; Sangamo eligible for up to $220M milestones and 14-20% royalties.","Fabry disease: 33 patients dosed, 17 off ERT; eGFR improvement observed."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-035160","json":"https://secwatch.observer/filing/0001628280-24-035160.json","markdown":"https://secwatch.observer/filing/0001628280-24-035160.md","text":"https://secwatch.observer/filing/0001628280-24-035160.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000162828024035160/0001628280-24-035160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000162828024035160/sgmo-20240806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:03:41.075752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}